The conventional paradigm of nonalcoholic fatty liver disease representing the “hepatic
manifestation of the metabolic syndrome” is outdated. We identified and summarized …

Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …

Non-alcoholic fatty liver disease (NAFLD) is the most frequent cause of liver disease in the
Western world. Furthermore, it is increasing worldwide, paralleling the obesity pandemic …

Liver fibrosis resulting from chronic liver injury are major causes of morbidity and mortality
worldwide. Among causes of hepatic fibrosis, viral infection is most common (hepatitis B and …

Coffee is one of the most commonly consumed beverages in the world. Its health benefits
including improved overall survival have been demonstrated in a variety of disease states …

NAFLD is the leading cause of chronic liver disease in the Western world with an estimated
prevalence of 20–30%. Lifestyle interventions targeted at weight loss through dietary …

Background & aims Diet plays a role in the onset and progression of metabolic disorders,
including non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS). We …

Introduction and objectives Non-alcoholic fatty liver disease (NAFLD) is a widespread
chronic liver disease. It is considered a multifactorial disorder that can progress to liver …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. In the
absence of effective pharmacotherapies, clinical guidelines focus primarily on weight loss to …

Objective Nonalcoholic fatty liver disease (NAFLD) is the most predominant chronic liver
disease worldwide. Effect of coffee on NAFLD risk and its potential dose–response patterns …